Albert Cha - 15 Oct 2026 Form 4 Insider Report for Frazier Life Sciences Acquisition Corp. II (FLSC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
15 Oct 2026, 16:40:32 UTC
Prior SEC filing
13 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Albert Cha
Filing notes and source

Key filing fact

Albert Cha filed Form 4 for Frazier Life Sciences Acquisition Corp. II (FLSC) on 15 Oct 2026.

Key facts

  • This page summarizes Albert Cha's Form 4 filing for Frazier Life Sciences Acquisition Corp. II (FLSC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 15 Oct 2026, 16:40.

Change

  • Previous filing in this sequence was filed on 13 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (5)

CIK 0001397906 Primary reporting owner

Cha Albert

Relationship
Chief Executive Officer, Director, 10%+ Owner
Address
1001 PAGE MILL ROAD, BUILDING 4, SUITE 200B, PALO ALTO
Signature
/s/ Albert Cha
Signature date
15 Oct 2026
CIK 0002153600

Frazier Life Sciences Holdings II LLC

Relationship
10%+ Owner
Address
1001 PAGE MILL ROAD, BUILDING 4, SUITE 200B, PALO ALTO
Signature
FRAZIER LIFE SCIENCES HOLDINGS II LLC, By: /s/ Albert Cha, Manager
Signature date
15 Oct 2026
CIK 0001863769

Frazier Life Sciences Public Fund, L.P.

Relationship
10%+ Owner
Address
1001 PAGE MILL ROAD, BUILDING 4, SUITE 200B, PALO ALTO
Signature
FRAZIER LIFE SCIENCES PUBLIC FUND, L.P., By: /s/ Albert Cha, Managing Member of General Partner of General Partner
Signature date
15 Oct 2026
CIK 0001879466

FHMLSP, L.P.

Relationship
10%+ Owner
Address
1001 PAGE MILL ROAD, BUILDING 4, SUITE 200B, PALO ALTO
Signature
FHMLSP, L.P., By: /s/ Albert Cha, Managing Member of General Partner
Signature date
15 Oct 2026
CIK 0001879465

FHMLSP, L.L.C.

Relationship
10%+ Owner
Address
1001 PAGE MILL ROAD, BUILDING 4, SUITE 200B, PALO ALTO
Signature
FHMLSP, L.L.C., By: /s/ Albert Cha, Managing Member
Signature date
15 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FLSC transaction

Class A ordinary shares

Purchase

Transaction value
Shares
+300,000
Change %
Price
$10.00*
Shares after
300,000
Date
15 Oct 2026
Ownership
By Frazier Life Sciences Holdings II LLC
Footnotes
F1
FLSC transaction

Class A ordinary shares

Purchase

Transaction value
Shares
+300,000
Change %
Price
$10.00*
Shares after
300,000
Date
15 Oct 2026
Ownership
By Frazier Life Sciences Holdings II LLC
Footnotes
F1
FLSC transaction

Class A ordinary shares

Purchase

Transaction value
Shares
+300,000
Change %
Price
$10.00*
Shares after
300,000
Date
15 Oct 2026
Ownership
By Frazier Life Sciences Holdings II LLC
Footnotes
F1
FLSC transaction

Class A ordinary shares

Purchase

Transaction value
Shares
+300,000
Change %
Price
$10.00*
Shares after
300,000
Date
15 Oct 2026
Ownership
By Frazier Life Sciences Holdings II LLC
Footnotes
F1
FLSC transaction

Class A ordinary shares

Purchase

Transaction value
Shares
+300,000
Change %
Price
$10.00*
Shares after
300,000
Date
15 Oct 2026
Ownership
By Frazier Life Sciences Holdings II LLC
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Securities held by Frazier Life Sciences Holdings II LLC ("Sponsor"). Albert Cha is the sole manager of Sponsor, and Frazier Life Sciences Public Fund, L.P. is its sole equity holder. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of its or his pecuniary interest therein, if any.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .